STAT3 and Cognitive impairment: Furthermore, treatment with SLT decreases LCN2 expression and the phosphorylation levels of Janus kinase-2 (JAK2) and signal transducer and activator of transcription-3 (STAT3) and mitigates the cognitive deficits in VaD rats.